✦ LIBER ✦

Intratumoral immunotherapy: using the tumour against itself

✍ Scribed by Marka R. Crittenden; Uma Thanarajasingam; Richard G. Vile; Michael J. Gough

Book ID: 108781559
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 421 KB
Volume: 114
Category: Article
ISSN: 0019-2805
DOI: 10.1111/j.1365-2567.2004.02001.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guiding the “misguided” – functional con

Guiding the “misguided” – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours

✍ Fang-Ping Huang; Yu-Xiao Chen; Christina KW To 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Memory T cells in cancer immunotherapy:

Memory T cells in cancer immunotherapy: which CD8+ T-cell population provides the best protection against tumours?

✍ R. Perret; F Ronchese 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Sentinel node lymphocytes: tumour reacti

Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer

✍ Marits, P; Karlsson, M; Dahl, K; Larsson, P; Wanders, A; Thörn, M; Winqvist, O 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

Assessment of apoptosis in human breast

Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics

✍ Hadjiloucas, I. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

The induction of tumor-specific CD4+ T c

The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells

✍ Yasuhiro Fujisawa; Tsukasa Nabekura; Tomohei Nakao; Yasuhiro Nakamura; Takenori 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Rapid and prognostically valid quantific

Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR

✍ Biesterfeld, Stefan; Klüppel, Dominik; Koch, Ralf; Schneider, Susanne; Steinhage 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 3 views

The prognostic significance of immunohistochemical markers for cell proliferation [MIB-1, proliferating cell nuclear antigen (PCNA)] and hormone receptor analysis [oestrogen receptor (ER), progesterone receptor (PR)] was tested by means of immunohistometry in a series of 103 breast cancer patients i